BRIDGEWATER, N.J., June 11, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it priced an...
Read More Details
Finally We wish PressBee provided you with enough information of ( Insmed Announces Pricing of $750 Million Public Offering of Common Stock )
Also on site :